EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome

George C. Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T. Boumpas, Nina Brodin, Ian N. Bruce, Miguel Ángel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltan SzekaneczAnne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary Macfarlane, Michael M. Ward, Michael T. Nurmohamed, Maria G. Tektonidou* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)
3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds